Serum Vascular Adhesion Protein-1 Level Predicts Risk of Incident Cancers in Subjects with Type II Diabetes

doi:10.1158/1055-9965.EPI-14-0023

CNU IR > College of Sustainable Environment and Recreation > Dept. of Occupational Safety > Periodical Articles > Item 310902800/28693

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/28693

Title:	Serum Vascular Adhesion Protein-1 Level Predicts Risk of Incident Cancers in Subjects with Type II Diabetes
Authors:	Yu, Tse-Ya Li, Hung-Yuan Jiang, Yi-Der Chang, Tien-Jyun Wei, Jung-Nan Lin, Chi-Ming Chu, Ching-Chi Chuang, Lee-Ming
Contributors:	職業安全衛生系
Keywords:	CHRONIC KIDNEY-DISEASE SENSITIVE AMINE OXIDASE COLORECTAL-CANCER PROSTATE-CANCER INFLAMMATION ASSOCIATION PROGRESSION MORTALITY METASTASES MOLECULE
Date:	2014-07
Issue Date:	2015-05-06 21:25:23 (UTC+8)
Publisher:	Amer Assoc Cancer Research
Abstract:	Background: Serum vascular adhesion protein-1 (VAP-1) predicts cancer-related mortality in diabetic subjects. However, whether serum VAP-1 predicts cancer incidence or cancer progression remains unclear. We conducted a cohort study to investigate whether serum VAP-1 and related clinical variables predict incident cancers in type II diabetic subjects. Methods: From 1996 to 2003, we enrolled 568 type II diabetic subjects who were free of cancer at baseline. Serum VAP-1 at enrollment was measured by time-resolved immunofluorometric assay. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate <60 mL/min per 1.73 m(2). The subjects were followed until first occurrence of cancer or until December 31, 2011. Results: During a mean follow-up of 11.3 years, 71 subjects developed incident cancers. The HRs for incident cancers in subjects with highest tertile of serum VAP-1 and in subjects with CKD were 2.95 [95% confidence interval (CI), 1.31-6.63; P = 0.009] and 2.29 (95% CI, 1.18-4.44; P = 0.015), respectively, after multivariate adjustment. There was an interaction between serum VAP-1 and CKD on the risk of incident cancers (P = 0.01 for log-transformed VAP-1 x CKD). The relationship among serum VAP-1, CKD, and incident cancers was similar if death was considered in the competing risk models or if subjects with shorter follow-up period were excluded. Conclusions: Higher serum VAP-1 and CKD can independently predict future development of cancers in type II diabetic subjects. Impact: Physicians should be aware of the early signs of cancer in diabetic individuals with elevated VAP-1 or renal dysfunction. More aggressive treatment strategies might be considered. (C)2014 AACR.
Relation:	Cancer Epidemiology Biomarkers & Prevention, v.23 n.7, pp.1366-1373
Appears in Collections:	[Dept. of Occupational Safety] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	2152	View/Open

Loading...